iSOFT Wins 2010 European Business Analytics Systems Competitive Strategy Leadership Award

iSOFTiSOFT Group Limited, one of the world's largest healthcare information technology companies, has received the Frost and Sullivan, 2010 European Business Analytics Systems Competitive Strategy Leadership Award.

HiNT is a powerful business analytics tool designed to empower modern healthcare organisations with business-critical information. By consolidating data from all the various applications within an organisation, users can view and explore information, trends and performance indicators covering all aspects of service delivery and financial performance. Designed around the latest clinical coding standards and with prebuilt reporting dashboards covering clinical activity, administration, finance and performance, Health Intelligence was seen as the market leader by Frost & Sullivan, and the clear winner for this award.

For the Competitive Strategy Leadership Award, the following criteria were used to benchmark iSOFT's performance against key competitors:

  • Leverage of competitive intelligence
  • Execution of competitive strategy
  • Impact on market share
  • Competitive brand positioning (brand strength and unique market position)
  • Impact on customer satisfaction/value

Through the overall product strategy, management and marketing, this award recognises iSOFT's growing market share and ongoing commitment to the healthcare sector.

The award was presented to Eamonn Morris, Managing Director of iSOFT Business Solutions, at a gala awards dinner in London on 19 May. Eamonn Morris said: "This is a significant achievement for iSOFT and illustrates the power and uniqueness of the iSOFT Health Intelligence solution, HiNT. Since taking the solution to market in late 2009, we have seen a huge interest from clients, prospects and partners in all territories across the globe. At iSOFT we have a dream, which is enhancing lives through innovative healthcare solutions; HiNT is a prime example of where iSOFT have designed and developed a solution which will add value to healthcare organisations worldwide, providing administrative, financial and clinical intelligence to enable informed decisions regarding the management and delivery of healthcare."

Frost & Sullivan acknowledges iSOFT's significant investments in research and development to improve the organisation's position, commenting, "iSOFT places more emphasis on providing user-friendly and efficient information and analytic solutions for its healthcare customers. Hundreds of hospitals have adopted iSOFT's healthcare information systems, as they offer greater return on investment."

A global network of iSOFT subsidiaries and partner networks provides significant support to the national healthcare markets, offering customers a complete suite of solutions and services around the world.

Related news articles:

About iSOFT Group
iSOFT Group Limited (ASX: ISF) is the largest health information technology company listed on the Australian Securities Exchange, and among the world's biggest providers of advanced application solutions in modern healthcare economies.

iSOFT works with healthcare professionals to design and build software applications that answer all of the difficult questions posed by today's healthcare delivery challenges. Our solutions act as a catalyst for change, supporting free exchange of critical information across diverse care settings and participating organizations.

Today, more than 13,000 provider organizations in about 40 countries use iSOFT's solutions to manage patient information and drive improvements in their core processes. The group's sustainable development is delivered through careful planning, in-depth analysis of the market, and anticipation of our clients' evolving requirements. Our business is driven by the collective talent, experience and commitment of more than 4,700 specialists, including more than 2,700 technology and development professionals.

A global network of iSOFT subsidiaries, supported by an extensive partner network, provides substantial experience of national healthcare markets. As a result, we offer our clients comprehensive knowledge of local market requirements in terms of culture, language, working practices, regulation and organizational structure.

www.isofthealth.com

About Frost and Sullivan
Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best in class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best practice models to drive the generation, evaluation and implementation of powerful growth strategies. Frost & Sullivan leverages almost 50 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 31 offices on six continents. To join our Growth Partnership, please visit www.frost.com.

Most Popular Now

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

A Novel AI-Based Method Reveals How Cell…

Researchers from Tel Aviv University have developed an innovative method that can help to understand better how cells behave in changing biological environments, such as those found within a cancerous...